Skip to main content
. 2020 Jan 15;9(2):e014402. doi: 10.1161/JAHA.119.014402

Table 3.

Incidences and Rates of MACE at 1‐Year of Follow‐Up

All Total Established Disease Any CADa Any CVDa Any PADa Multiple Risk Factors Only
N=1 220 144 Events/100 PY (95% CI) n (%) N=414 718 Events/100 PY (95% CI) n (%) N=206 804 Events/100 PY (95% CI) n (%) N=92 695 Events/100 PY (95% CI) n (%) N=165 967 Events/100 PY (95% CI) n (%) N=805 426 Events/100 PY (95% CI) n (%)
MACE 1.47 (1.45–1.49) 2.12 (2.07–2.16) 2.19 (2.12–2.25) 3.04 (2.93–3.16) 2.04 (1.97–2.11) 1.14 (1.11–1.16)
17 671 (1.4) 8620 (2.1) 4437 (2.1) 2749 (3.0) 3322 (2.0) 9051 (1.1)
Myocardial infarction 0.77 (0.76–0.79) 1.14 (1.11–1.17) 1.44 (1.39–1.49) 1.07 (1.00–1.13) 1.11 (1.06–1.16) 0.59 (0.57–0.60)
9320 (0.8) 4648 (1.1) 2922 (1.4) 971 (1) 1812 (1.1) 4672 (0.6)
Ischemic stroke 0.64 (0.62–0.65) 0.88 (0.86–0.91) 0.65 (0.61–0.68) 1.89 (1.80–1.98) 0.81 (0.77–0.86) 0.51 (0.49–0.52)
7669 (0.6) 3616 (0.9) 1325 (0.6) 1713 (1.8) 1333 (0.8) 4053 (0.5)
Cardiovascular death 0.16 (0.15–0.17) 0.23 (0.22–0.25) 0.23 (0.21–0.25) 0.31 (0.27–0.35) 0.26 (0.24–0.29) 0.12 (0.11–0.13)
1914 (0.2) 955 (0.2) 475 (0.2) 283 (0.3) 426 (0.3) 959 (0.1)

CAD indicates coronary artery disease; CVD, cerebrovascular disease; MACE, major adverse cardiovascular event; PAD, peripheral artery disease; PY, person‐years.

a

These cohorts overlap each other.